Why Is Subtotal Resection Used for Schwannoma Surgery?
At a Glance
Subtotal resection may be used for a benign schwannoma when complete removal could damage an attached nerve or nearby brain structures. The remnant is usually watched with MRI and treated only if it grows or causes problems.
In this answer
3 sections
When a surgeon intentionally leaves a small piece of a benign schwannoma behind, it is a calculated decision designed to protect your nervous system. Schwannomas arise from the protective sheath surrounding a nerve. In some cases, the tumor becomes densely adherent (firmly attached) to the nerve itself or to nearby critical brain structures. Because these tumors are benign (non-cancerous), surgeons often choose to leave a tiny remnant behind rather than risk causing permanent nerve damage by trying to remove every microscopic cell [1].
While this nerve-preserving approach can be used for various schwannomas (such as spinal or trigeminal schwannomas), it is most commonly discussed and researched in the context of vestibular schwannomas (acoustic neuromas), which grow near the nerves responsible for hearing, balance, and facial movement.
The Trade-Off: Nerve Preservation vs. Total Removal
In schwannoma surgery, surgeons classify their results based on how much of the tumor is removed. Gross-total resection means the entire visible tumor was taken out. However, aiming for complete removal can be dangerous if the tumor is deeply intertwined with delicate structures. Instead, the surgeon may opt for a partial removal, a technique often called capsule preservation [1].
Depending on how much is left, this is typically categorized as:
- Near-total resection: Leaving a minuscule fragment (often just the thin capsule wall).
- Subtotal resection: Leaving a slightly larger, measurable portion of the tumor [2].
Note: The exact definitions of these terms can vary between hospitals. What matters most is the actual volume and location of the tumor left behind, which will be measured on your postoperative MRI.
The primary goal of leaving a small piece behind is to protect nerve function [3]. For example, if a vestibular schwannoma is densely adherent to the facial nerve, aggressively peeling it away could convert a working nerve into a permanent neurologic deficit, such as the inability to blink, smile, or move one side of your face [1][4]. Studies show that utilizing a near-total or subtotal approach can improve the chances of preserving facial movement compared to pursuing complete removal in difficult cases [4][2]. However, it is important to understand that a nerve-preserving strategy lowers the immediate risk of injury but trades it for a risk of future tumor growth, and it does not guarantee that your hearing or facial function will be perfectly preserved.
What Are the Chances of the Tumor Growing Back?
Because a piece of the tumor remains, there is a possibility that it could slowly grow over time. However, regrowth is not guaranteed.
Research tracking patients with vestibular schwannomas over several years indicates that across those who have a subtotal or near-total resection, the remaining tumor grows in roughly 17% to 30% of cases [5][6]. The risk depends heavily on the volume of the remnant:
- Near-total resections carry a lower and generally slower risk of regrowth [7][8].
- Subtotal resections have a higher chance of the remnant growing back [8][6].
Overall, larger leftover tumor volumes, larger original tumor sizes, and younger patient age are the most consistent predictors that a remnant might grow [9][5]. Keep in mind that late growth can sometimes occur many years after surgery, which is why long-term monitoring is essential [10].
Managing the Leftover Tumor
Discovering that a piece of your tumor was left behind can feel as though the surgery “failed,” but this is a standard, planned part of modern neurosurgery. You will not necessarily need immediate treatment for the remnant.
For most patients, the leftover piece is managed with ongoing surveillance. You will undergo an initial baseline MRI after surgery, followed by regular MRI scans to monitor the remnant [5][10]. If the tissue remains stable, you will not need additional treatment, though you will still need lifelong or extended monitoring to ensure it doesn’t change [10][11].
If an MRI eventually shows that the tiny piece is starting to grow, your medical team will discuss your options. Depending on the size, location, and your overall health, options may include:
- Continued observation if the growth is very slow and not causing symptoms.
- Stereotactic radiosurgery (SRS), a highly targeted form of radiation that aims to stop the tumor cells from growing without another open surgery [5][11].
- Repeat surgery or fractionated radiation in specific cases.
Delaying radiation until the tumor actually shows signs of growth is an evidence-supported strategy that provides strong long-term control while preventing unnecessary treatment of a stable remnant [10][11].
Postoperative Safety Warning
Regardless of the type of resection you had, contact your surgical team immediately if you experience new or worsening facial weakness, an inability to close your eye (which requires immediate eye protection to prevent corneal injury), severe headaches, fever, or clear fluid leaking from your nose or incision.
Common questions in this guide
Why would a surgeon leave part of a benign schwannoma behind?
What is the difference between subtotal, near-total, and gross-total resection?
How likely is a schwannoma remnant to grow after surgery?
What MRI follow-up is needed after subtotal schwannoma surgery?
What happens if the remaining schwannoma starts to grow?
Which symptoms require urgent contact with the surgical team?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did you achieve a gross-total, near-total, or subtotal resection, and what is the estimated volume of the tumor left behind?
- 2.Which specific nerves was the tumor capsule adherent to, and how is their function currently?
- 3.What is our schedule for MRI monitoring to establish a baseline and watch the remnant over time?
- 4.If the remaining tumor starts to grow, what treatment options (such as radiosurgery or another surgery) would you recommend for my specific case?
- 5.What signs or symptoms (like changes in facial movement or eye closure) should prompt me to contact you immediately?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Intended Near-Total Removal of Koos Grade IV Vestibular Schwannomas: Reconsidering the Treatment Paradigm.
Zumofen DW, Guffi T, Epple C, et al.
Neurosurgery 2018; (82(2)):202-210 doi:10.1093/neuros/nyx143.
PMID: 28383680 - 2
The Influence of Extent of Resection and Tumor Morphology on Facial Nerve Outcomes Following Vestibular Schwannoma Surgery.
Perkins EL, Manzoor NF, Totten DJ, et al.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2021; (42(9)):e1346-e1352 doi:10.1097/MAO.0000000000003253.
PMID: 34238899 - 3
Role of electrophysiology in guiding near-total resection for preservation of facial nerve function in the surgical treatment of large vestibular schwannomas.
Bernardeschi D, Pyatigorskaya N, Vanier A, et al.
Journal of neurosurgery 2018; (128(3)):903-910.
PMID: 28409723 - 4
Near Total Versus Gross Total Resection of Large Vestibular Schwannomas: Facial Nerve Outcome.
Schneider JR, Chiluwal AK, Arapi O, et al.
Operative neurosurgery (Hagerstown, Md.) 2020; (19(4)):414-421 doi:10.1093/ons/opaa056.
PMID: 32330283 - 5
Residual Vestibular Schwannomas: Proposed Age-Tumor-Residual (ATR) Staging System to Predict Future Growth.
Totten DJ, Cumpston EC, Schneider W, et al.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2024; (45(10)):1172-1177 doi:10.1097/MAO.0000000000004339.
PMID: 39439051 - 6
Residual Tumor Volume and Location Predict Progression After Primary Subtotal Resection of Sporadic Vestibular Schwannomas: A Retrospective Volumetric Study.
Breshears JD, Morshed RA, Molinaro AM, et al.
Neurosurgery 2020; (86(3)):410-416 doi:10.1093/neuros/nyz200.
PMID: 31232426 - 7
Intentional Subtotal Resection of Vestibular Schwannoma: A Reexamination.
Strickland BA, Ravina K, Rennert RC, et al.
Journal of neurological surgery. Part B, Skull base 2020; (81(2)):136-141 doi:10.1055/s-0039-1679898.
PMID: 32206531 - 8
Volumetric analysis of tumor control following subtotal and near-total resection of vestibular schwannoma.
Jacob JT, Carlson ML, Driscoll CL, Link MJ
The Laryngoscope 2016; (126(8)):1877-82 doi:10.1002/lary.25779.
PMID: 27426941 - 9
Extent of resection and progression-free survival in vestibular schwannoma: a volumetric analysis.
Nandoliya KR, Khazanchi R, Winterhalter EJ, et al.
Journal of neurosurgery 2025; (142(1)):230-238 doi:10.3171/2024.4.JNS24157.
PMID: 39094197 - 10
The behavior of residual tumors following incomplete surgical resection for vestibular schwannomas.
Park HH, Park SH, Oh HC, et al.
Scientific reports 2021; (11(1)):4665 doi:10.1038/s41598-021-84319-1.
PMID: 33633337 - 11
Salvage radiosurgery following subtotal resection of vestibular schwannomas: does timing influence tumor control?
Dhayalan D, Perry A, Graffeo CS, et al.
Journal of neurosurgery 2023; (138(2)):420-429 doi:10.3171/2022.5.JNS22249.
PMID: 35907189
This page is for informational purposes only and does not constitute medical advice. Your neurosurgical team should explain why a schwannoma remnant was left and how it will be monitored in your specific case.
Get notified when new evidence is published on Benign schwannoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.